Trial Profile
Effects of Low Dose Naltrexone on Quality of Life in High Grade Glioma Patients: A Placebo-Controlled, Double-Blind Randomized Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Mar 2022
Price :
$35
*
At a glance
- Drugs Naltrexone (Primary) ; Temozolomide
- Indications Glioma
- Focus Pharmacodynamics; Therapeutic Use
- 01 Apr 2022 Results assessing effects of low-dose naltrexone on quality of life in high-grade glioma patients, published in the Supportive Care in Cancer
- 25 Jun 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov record.
- 12 Mar 2015 Planned End Date changed from 1 Dec 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov